Eric S. Marr

1.8k total citations
15 papers, 916 citations indexed

About

Eric S. Marr is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Eric S. Marr has authored 15 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Genetics. Recurrent topics in Eric S. Marr's work include Protein Structure and Dynamics (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Eric S. Marr is often cited by papers focused on Protein Structure and Dynamics (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Eric S. Marr collaborates with scholars based in United States, United Kingdom and Spain. Eric S. Marr's co-authors include Lise R. Hoth, Jayvardhan Pandit, Frank S. Menniti, Spiros Liras, Seungil Han, Xinjun Hou, Veerabahu Shanmugasundaram, Christopher J. Schmidt, Richard P. Zaniewski and Shenping Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Eric S. Marr

15 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric S. Marr United States 12 621 259 190 89 88 15 916
Ryan E. Pavlovicz United States 15 766 1.2× 88 0.3× 90 0.5× 55 0.6× 82 0.9× 24 1.3k
Martín Brandt United States 19 682 1.1× 100 0.4× 217 1.1× 77 0.9× 27 0.3× 45 1.2k
Laura B. Peterson United States 15 662 1.1× 68 0.3× 186 1.0× 102 1.1× 59 0.7× 16 935
Fisayo A. Olotu South Africa 18 439 0.7× 73 0.3× 160 0.8× 70 0.8× 42 0.5× 79 857
Silvia Gervasoni Italy 15 360 0.6× 67 0.3× 107 0.6× 158 1.8× 57 0.6× 49 814
Thomas Ryckmans United Kingdom 15 499 0.8× 72 0.3× 305 1.6× 34 0.4× 30 0.3× 29 877
Mamoun M. Alhamadsheh United States 16 684 1.1× 397 1.5× 234 1.2× 17 0.2× 29 0.3× 28 1.1k
Stephan K. Grant United States 17 578 0.9× 64 0.2× 247 1.3× 25 0.3× 120 1.4× 26 1.0k
Jelena Dinić Serbia 19 671 1.1× 67 0.3× 168 0.9× 77 0.9× 30 0.3× 65 1.1k
Serdar Kurtkaya United States 8 434 0.7× 83 0.3× 158 0.8× 100 1.1× 222 2.5× 8 756

Countries citing papers authored by Eric S. Marr

Since Specialization
Citations

This map shows the geographic impact of Eric S. Marr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Marr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Marr more than expected).

Fields of papers citing papers by Eric S. Marr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric S. Marr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Marr. The network helps show where Eric S. Marr may publish in the future.

Co-authorship network of co-authors of Eric S. Marr

This figure shows the co-authorship network connecting the top 25 collaborators of Eric S. Marr. A scholar is included among the top collaborators of Eric S. Marr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric S. Marr. Eric S. Marr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ferruz, Noelia, Stefan Doerr, Michelle Vanase‐Frawley, et al.. (2018). Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs. Scientific Reports. 8(1). 897–897. 44 indexed citations
2.
Magee, Thomas V., Seungil Han, Sandra P. McCurdy, et al.. (2013). Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates. Bioorganic & Medicinal Chemistry Letters. 23(6). 1727–1731. 18 indexed citations
3.
Liu, Shenping, Xi Song, Boris A. Chrunyk, et al.. (2013). Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Nature Communications. 4(1). 1888–1888. 99 indexed citations
4.
Patel, Nandini C., Jacob B. Schwarz, Xinjun Hou, et al.. (2013). Discovery and Characterization of a Novel Dihydroisoxazole Class of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators. Journal of Medicinal Chemistry. 56(22). 9180–9191. 18 indexed citations
5.
Rajamohan, Francis, Eric S. Marr, Allan R. Reyes, et al.. (2011). Structure-guided Inhibitor Design for Human Acetyl-coenzyme A Carboxylase by Interspecies Active Site Conversion. Journal of Biological Chemistry. 286(48). 41510–41519. 5 indexed citations
6.
Han, Seungil, Richard P. Zaniewski, Eric S. Marr, et al.. (2010). Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains ofPseudomonas aeruginosa. Proceedings of the National Academy of Sciences. 107(51). 22002–22007. 130 indexed citations
7.
8.
McLellan, Thomas J., Eric S. Marr, L Wondrack, et al.. (2009). A systematic study of 50S ribosomal subunit purification enabling robust crystallization. Acta Crystallographica Section D Biological Crystallography. 65(12). 1270–1282. 14 indexed citations
9.
Simons, Samuel P., Thomas J. McLellan, Paul A. Aeed, et al.. (2009). Purification of the large ribosomal subunit via its association with the small subunit. Analytical Biochemistry. 395(1). 77–85. 6 indexed citations
10.
Verhoest, Patrick R., Michael L. Corman, Christopher J. Helal, et al.. (2009). Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy. Journal of Medicinal Chemistry. 52(24). 7946–7949. 45 indexed citations
11.
Lippa, Blaise, Gonghua Pan, Matthew S. Corbett, et al.. (2008). Synthesis and structure based optimization of novel Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3359–3363. 64 indexed citations
12.
Marr, Eric S., et al.. (2006). Expression, purification, crystallization and structure of human adipocyte lipid-binding protein (aP2). Acta Crystallographica Section F Structural Biology and Crystallization Communications. 62(11). 1058–1060. 30 indexed citations
13.
Chappie, Thomas A., John M. Humphrey, Martin P. Allen, et al.. (2006). Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors. Journal of Medicinal Chemistry. 50(2). 182–185. 93 indexed citations
14.
Geoghegan, Kieran F., H. B. F. Dixon, Lise R. Hoth, et al.. (1999). Spontaneous α-N-6-Phosphogluconoylation of a “His Tag” inEscherichia coli:The Cause of Extra Mass of 258 or 178 Da in Fusion Proteins. Analytical Biochemistry. 267(1). 169–184. 177 indexed citations
15.
Swanson, Rosemarie, Eric S. Marr, & James R. Wild. (1992). Instructions for constructing a small “working” model of an allosteric enzyme. Biochemical Education. 20(3). 171–173. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan E. Pavlovicz Breakdown of academic impact, for papers by Martín Brandt Breakdown of academic impact, for papers by Laura B. Peterson Breakdown of academic impact, for papers by Fisayo A. Olotu Breakdown of academic impact, for papers by Silvia Gervasoni Breakdown of academic impact, for papers by Thomas Ryckmans Breakdown of academic impact, for papers by Mamoun M. Alhamadsheh Breakdown of academic impact, for papers by Stephan K. Grant Breakdown of academic impact, for papers by Jelena Dinić Breakdown of academic impact, for papers by Serdar Kurtkaya
Rankless by CCL
2026